Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease

Chest

Volumn 131, Issue 4, 2007, Pages 988-992

  Fischer, Aryeh ^a   Misumi, Shigeki ^a   Curran Everett, Douglas ^a   Meehan, Richard T ^a   Ulrich, Sandra K ^a   Swigris, Jeffrey J ^a   Frankel, Stephen K ^a   Cosgrove, Gregory P ^a   Lynch, David A ^a   Brown, Kevin K ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Interstitial lung disease; Pericardial abnormalities; Pulmonary arterial hypertension; Systemic sclerosis

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEMOGRAPHY; ECHOCARDIOGRAPHY; ESOPHAGUS DILATATION; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MALE; PERICARDIAL DISEASE; PERICARDIAL EFFUSION; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL ANALYSIS; SYSTEMIC SCLEROSIS; TOTAL LUNG CAPACITY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 34247186501     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2317     Document Type: Article

References (27)

1. Steen VD. Epidemiology of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, et al, eds. Rheumatology. Madrid, Spain: Elsevier Limited, 2003; 1455-1462
2. Chang B, Wigley FB, White B, et al. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 2003; 30:2398-2405
3. Hinderliter AL, Willis PW, Long W, et al. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. Am J Cardiol 1999; 84:481-484
4. Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002; 39:1214-1219
5. Steen V. The heart in systemic sclerosis. Curr Rheum Rep 2004; 6:137-140
6. Preliminary criteria for the classification of systemic sclerosis (scleroderma); special article. Arthritis Rheum 1980; 23:581-590
7. Bacque-Juston MC, Wells AU, Hansell DM. Pericardial thickening or effusion in patients with pulmonary artery hypertension: a CT study. AJR Am J Roentgenol 1999; 172:361-364
8. Deswal A, Follansbee WP. Cardiac involvement in scleroderma. Rheum Dis Clin North Am 1996; 22:841-860
9. Oram S, Stokes W. The heart in scleroderma. Br Heart J 1961; 23:243-259
10. Sackner MA, Heinz ER, Steinberg AJ. The heart in scleroderma. Am J Cardiol 1966; 17:542-559
11. D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma): a study of 58 autopsy cases and 58 matched controls. Am J Med 1969; 46:428-440
12. McWorther JE, LeRoy EC. Pericardial disease in scleroderma (systemic sclerosis). Am J Med 1974; 57:566-575
13. Bulkley BH, Ridolfi RL, Salyer WR, et al. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976; 53:483-490
14. Steen V, Medsger TA. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48:516-522
15. Smith JW, Clements PJ, Levisman J, et al. Echokardiographic features of progressive systemic sclerosis (PSS): correlation with hemodynamic and postmortem studies. Am J Med 1979; 66: 28-33
16. Gottdiener JS, Mousopoulos HM, Decker JL. Echocardiographic identification of cardiac abnormality in scleroderma and related disorders. Am J Med 1979; 66:391-398
17. Gaffney FA, Anderson RJ, Nixon JV, et al. Cardiovascular function in patients with progressive systemic sclerosis (scleroderma). Clin Cardiol 1982; 5:569-576
18. Follansbee WP, Curtiss EI, Medsger TA, et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984; 310:142-148
19. Follansbee WP, Curtiss EI, Medsger TA, et al. Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis: exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med 1984; 77:489-496
20. Park B, Dittrich HC, Polikar R, et al. Echocardiographic evidence of pericardial effusion in severe chronic pulmonary hypertension. Am J Cardiol 1989; 63:143-145
21. Gibson AT, Segal MB. A study of the composition of pericardial fluid with special reference to the probable mechanism of fluid accumulation. J Physiol 1978; 277:367-377
22. Murata I, Kihara H, Shinohara S, et al. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. Jpn Circ J 1992; 56:983-991
23. Hinderliter AL, Willis PW, Barst RJ, et al, for the Primary Pulmonary Hypertension Study Group. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 1997; 95:1479-1486
24. Bossone E, Duong-Wagner TH, Paciocco G, et al. Echocardiographic features of primary pulmonary hypertension. J Am Soc Echocardiogr 1999; 12:655-662
25. Pilaris ND, Jacobs LE, Rerkpattanapipat P, et al. Clinical predictors of pulmonary hypertension in patients undergoing liver transplant evaluation. Liver Transpl 2000; 6:8-5-91
26. Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128:2393-2399
27. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126:14S-34S